- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide (Revlimid)
Total 1146 results
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
CelgeneCompletedLymphoma, Mantle-CellUnited States, Germany, Italy, United Kingdom
-
CelgeneWithdrawnNeoplasms | Hematologic Diseases | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Therapeutic Uses | Plasma Cells
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
M.D. Anderson Cancer CenterCompleted
-
PETHEMA FoundationCelgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
Cantonal Hospital of St. GallenCelgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...Completed
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Italy, Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Poland, United States, United Kingdom, Turkey, Belgium, Thailand, Czechia
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
University of California, DavisCelgeneActive, not recruiting
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedMultiple MyelomaUnited States
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Dana-Farber Cancer InstituteCelgeneActive, not recruitingLangerhans Cell Histiocytosis (LCH) | Histiocytoses Erdheim-chester Disease | Histiocytic Sarcoma (HS)United States
-
Washington University School of MedicineCelgene CorporationCompletedHodgkin DiseaseUnited States
-
University of FloridaCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, MyeloidUnited States
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Relapsed Adult Acute Lymphocytic LeukemiaUnited States
-
Columbia UniversityCelgene CorporationCompleted
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
Mehrdad Abedi, MDCelgeneTerminated
-
CelgeneCompletedAdult T-Cell Leukemia-LymphomaJapan
-
Ulsan University HospitalCooperative Study Group A for HematologyUnknownMyelodysplastic SyndromeKorea, Republic of
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Beth Israel Deaconess Medical CenterAmerican Medical AssociationCompletedAcute Respiratory FailureUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
The Lymphoma Academic Research OrganisationCompletedLymphoma | Diffuse Large B-cell LymphomaBelgium, Switzerland, France, Australia, Spain, Israel, Austria, Portugal, Poland
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Gesellschaft fur Medizinische Innovation - Hamatologie...CompletedComparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple MyelomaMultiple MyelomaGermany
-
Jun ZhangBaylor College of Medicine; Celgene CorporationTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...TerminatedB-cell Chronic Lymphocytic LeukemiaUnited States
-
Washington University School of MedicineCompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLLUnited States
-
CelgeneRecruitingLymphoma, Mantle-CellSpain, Italy, Germany, Austria, France, Greece, Netherlands
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
University Hospital, LilleCelgene CorporationCompletedWaldenstrom MacroglobulinemiaFrance
-
Technische Universität DresdenCelgene CorporationTerminatedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaGermany
-
Sutter Medical FoundationCompleted
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Nordic MDS GroupCompleted